Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HDAC2 |
| Upstream (Parents) |
|---|
| (<<) ASNS → HDAC2 |
| (<<) BZW2 → HDAC2 |
| (<<) CCNB2 → HDAC2 |
| (<<) MYC → HDAC2 |
| (<<) RBKS → HDAC2 |
| (<<) SET → HDAC2 |
| (<<) TUBA1B → HDAC2 |
| (<<) UBE2C → HDAC2 |
| (<<) UBE2N → HDAC2 |
| Downstream (Children) |
|---|
| HDAC2 → ABCF1 (>>) |
| HDAC2 → BCL2L13 (>>) |
| HDAC2 → BLNK (>>) |
| HDAC2 → CCNE1 (>>) |
| HDAC2 → CD3EAP (>>) |
| HDAC2 → CD79A (>>) |
| HDAC2 → CREB3L1 (>>) |
| HDAC2 → E2F3 (>>) |
| HDAC2 → EEF1E1 (>>) |
| HDAC2 → EIF6 (>>) |
| HDAC2 → EPHB3 (>>) |
| HDAC2 → FERMT1 (>>) |
| HDAC2 → FNBP1 (>>) |
| HDAC2 → G0S2 (>>) |
| HDAC2 → GAL (>>) |
| HDAC2 → HSP90AB1 (>>) |
| HDAC2 → IGFBP4 (>>) |
| HDAC2 → ITCH (>>) |
| HDAC2 → JUN (>>) |
| HDAC2 → KLF11 (>>) |
| HDAC2 → MAP3K4 (>>) |
| HDAC2 → MAPK13 (>>) |
| HDAC2 → PPAP2A (>>) |
| HDAC2 → RAF1 (>>) |
| HDAC2 → RB1 (>>) |
| HDAC2 → RPIA (>>) |
| HDAC2 → RPS16 (>>) |
| HDAC2 → SFN (>>) |
| HDAC2 → SLC7A5 (>>) |
| HDAC2 → SLMO2 (>>) |
| HDAC2 → SPRY2 (>>) |
| HDAC2 → TARS (>>) |
| HDAC2 → TYRO3 (>>) |
| HDAC2 → UBE2L6 (>>) |
| HDAC2 → YWHAB (>>) |
